Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyadenylate-binding protein 1 (PABPC1) is an RNA-binding protein that binds specifically to the poly(A) tail at the 3' end of eukaryotic messenger RNAs. It plays a central role in regulating various aspects of mRNA metabolism, including stability, transport between nucleus and cytoplasm, translation efficiency, and degradation. PABPC1 contains four RNA recognition motifs (RRMs) that mediate its binding to polyadenylated RNA sequences with high specificity. In addition to its interaction with RNA, it has a C-terminal MLLE/PABC domain that mediates interactions with regulatory proteins such as eukaryotic release factor 3 (eRF3), PAIP1, PAIP2, and others involved in translational control. While essential for normal cell function and implicated in processes like stress granule formation or viral infection response, PABPC1 itself is not considered a classical therapeutic target such as an enzyme or receptor. The submitted name "Ribonucleoprotein complex containing polyadenylate binding protein‑1" is overly broad; the canonical molecular entity relevant for structured data is "Polyadenylate-binding protein 1" (PABPC1).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyadenylate-binding protein 1 (PABPC1).